Home Business Amazon already undercutting prices on over-the-counter pills
As pharmacy chains await Amazon.com Inc’s entry into the prescription-drug market, the online retail giant is already undercutting them for non-prescription medicine for aches, colds and allergies.
Median prices for over-the-counter, private-brand medicine sold by Walgreens Boots Alliance Inc and CVS Health Corp were about 20% higher than Basic Care, the over-the-counter drug line sold exclusively by Amazon, according to a report Friday by Jefferies Group analysts.
Last week, Amazon announced that it was buying PillPack, a pharmacy company that will give it an entry point into the US’ US$328.6bil market for prescription drugs. Shares of CVS and Walgreens plunged on the news, as investors bet Amazon could lure pharmacy customers with lower prices, and give them one less reason to go to the corner drugstore.
Amazon began selling the Basic Care line in August with roughly 35 products and has since expanded its range to 65 drugs, according to the Jefferies analysts. The products include mild painkillers, cold and flu medication, sleeping aids and other medication commonly found in the pharmacy aisle.
According to the Jefferies report, 84% of Walgreens’ and 72% of CVS’s house-brand drugs were more expensive than the Basic Care line.
In-house brands are a way for retailers to sell over-the-counter products that can compete with manufacturers’ brand offerings, such as Tylenol or Advil. Amazon’s Basic Care brand is made by Perrigo Co, which also makes in-house brands for other retailers.
Many, but not all, of Amazon’s over-the-counter drugs are available through the retailer’s Prime service, which offers free shipping and fast delivery.
Nell Rona, an Amazon spokeswoman, declined to say how the Basic Care brands were performing financially.
Erin Pensa, a spokeswoman for CVS, said the company regularly evaluates its pricing strategy to stay competitive. Walgreens spokesman Jim Cohn said the retailer is expanding its own product lines and offering more personalised services by its pharmacists. — Bloomberg